Science
Mechanism of Action
Cilostamide selectively inhibits phosphodiesterase type 3 (PDE3), an enzyme responsible for hydrolyzing cyclic AMP (cAMP). This inhibition leads to an elevation in intracellular cAMP concentrations within skin cells. Increased cAMP levels can broadly reduce the production of pro-inflammatory cytokines, including TNF-α, IL-23, IL-17, IFN-γ, IL-4, IL-5, IL-13, and IL-22, while potentially increasing anti-inflammatory cytokines like IL-10. Furthermore, this action may contribute to correcting dysregulated genes vital for maintaining skin barrier integrity and decreasing sensory neuron activation associated with itch. However, it is crucial to note that these effects are generalized observations for PDE inhibitors, and specific topical cutaneous efficacy for Cilostamide in cosmetic applications has not been detailed in available research.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Cilostamide is an FDA-approved oral medication, not a conventional cosmetic ingredient. There is no current evidence to suggest it is commonly 'dusted' in cosmetic formulations to imply unsubstantiated benefits, primarily due to the absence of established topical efficacy data.
The Formula
Formulation
Stability
Cilostamide demonstrates solubility in oil. Laboratory stock solutions are noted to be stable for up to 6 months when refrigerated at 4°C. However, comprehensive stability data, including optimal pH ranges, for Cilostamide specifically within cosmetic formulations are not extensively documented. General recommendations for topical product pH typically fall within the 4 to 6.5 range to support skin barrier function and overall product stability.
Safety
Safety Profile
Cilostamide is an FDA-approved drug for oral use in medical applications. However, its safety for topical cosmetic use has not been formally reviewed by cosmetic regulatory bodies such as the CIR or SCCS. The FDA primarily places the responsibility for cosmetic ingredient safety on manufacturers, with no specific restrictions or maximum concentrations for cosmetic use of Cilostamide identified in public data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Cilostamide's PDE3 inhibitory mechanism holds theoretical promise for anti-inflammatory and barrier-supporting benefits, the profound lack of specific topical clinical efficacy and safety data for cosmetic applications warrants a cautious approach.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources